Medicus Pharma Ltd. Common Stock (MDCX) vs MetaVia Inc. (MTVA)
A side-by-side comparison of Medicus Pharma Ltd. Common Stock and MetaVia Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
MDCX
Medicus Pharma Ltd. Common Stock
$0.16HealthcareDelayed quote: Oct 6, 2026, 12:00 PM EDT
MTVA
MetaVia Inc.
$1.47HealthcareDelayed quote: Oct 6, 2026, 11:59 AM EDT
Total return — MDCX vs MTVA
growth of $100 · dividends reinvested · last 2yMDCX -93.7% (-74.9%/yr)MTVA -94.1% (-75.8%/yr)MDCX compounded faster over this window
MDCX MTVA
MDCX vs MTVA: by the numbers
- •MDCX is the larger company ($10M vs $10M market cap).
Metrics side by side
Valuation
| Metric | MDCX | MTVA |
|---|---|---|
| P/B ratio | N/A | 1.42 |
Profitability
| Metric | MDCX | MTVA |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | N/A | -211.76% |
| ROIC | -269.16% | -215.61% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.